Table: begin end state 1 12 non-cytoplasmic 13 32 transmembrane 33 60 cytoplasmic 61 86 transmembrane 87 91 non-cytoplasmic 92 112 transmembrane 113 142 cytoplasmic 143 165 transmembrane 166 175 non-cytoplasmic 176 196 transmembrane 197 207 cytoplasmic 208 229 transmembrane 230 234 non-cytoplasmic 235 259 transmembrane 260 295 cytoplasmic 296 318 transmembrane 319 347 non-cytoplasmic 348 368 transmembrane 369 379 cytoplasmic 380 400 transmembrane 401 405 non-cytoplasmic 406 429 transmembrane 430 492 cytoplasmic
Input: >WP_086509070.1 NCBI__GCF_002151265.1:WP_086509070.1 MLDLINDLLWGKVLIALLIAVGVGFTLSSRFVQFRYFARMFRILGASQAFKRDKHGHLSS FQALLLSIAGRVGGGNIAGVAVAITLGGPGAIFWMWLVGLMGMATSFLECTLAQAYKTAQ PDGTYRGGPAYYIARGLGSRWKWLAALYSVLLLVTFGFGFTALQSYAVATSFDDAFGIPV LYTGIGMAAVVGLIIFGGIKRIARVTEVLVPVMAVGYLLIAFVVLGMNLPRIPEVFLLIV NSAFGLEPAVGGGIGAAIMMGVKRGLFSNEAGLGSAPNVAAVAYVPHPANQGVVQAFSVF IDTLIICSATAFIILLSGAYDPASGADIGGVALTQVSLADHVGEWGRSFVSVALLLFGFS TILYNYYLGENSLNYFSDGNVTLFNLFRIAIVALCAWGALTDLGTVFAFADVTMGFLALA NLIALLMLFKPGLRLMRDFDEQIRAGIRHPVFDAQKFADLDIDPAAWEIEPEDIERLKRY GAAAPTAGQPAK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server